Tackling obesity by offering the opportunity to attend a weight loss programme during a routine consultation is effective, welcomed by patients and takes 30 seconds of physicians’ time, according to a new randomised trial of more than 1,800 people published in The Lancet.
The findings should provide reassurance to doctors who rarely talk to patients about their weight for fear of causing offence, lack of time or belief that they are ineffective. The authors say the low-cost intervention should be considered as the first point of call for GPs in treating obesity.
The trial, led by the University of Oxford, included 137 GPs in England and 1,882 people attending a consultation unrelated to weight loss. At the end of the consultation, participants were randomly allocated to receive one of two 30-second interventions. Half were offered a 12-week weight management programme available for free on the NHS. If the referral was accepted, the GP ensured the first appointment was made for the participant and offered follow up. The typical conversation with the GP began with ‘While you’re here, I just wanted to talk about your weight…’
The other half were advised by their GP that losing weight would benefit their health. All participants were weighed at the first consultation, then at three months they were asked whether they had taken any action to manage their weight. They were weighed again at 12 months.
Over three quarters (77%) of those offered the intervention agreed to take part in the weight management programme, and 40% attended. The average weight at the start of the trial was approximately 105kg for men and 93kg for women. People in the referral group lost on average 1.43kg more weight than those in the control group (2.43kg average weight loss in the referral group, compared with 1.04kg in the control group). Furthermore, a quarter of participants in the referral group had lost at least 5% of their body weight after a year, and 12% had lost at least 10% – double the rate of the control group.
Importantly, the majority of people (81%) across both groups found the intervention appropriate and helpful, while only four people found it inappropriate and unhelpful. Over the 12 months of the trial, a similar proportion of people in both groups had taken some action to lose weight, but approximately five times more people in the referral group had taken effective action.
Guidelines recommend that physicians screen for obesity and offer referral to weight loss programmes, but in reality doctors rarely intervene because of a lack of time, fear of causing offence or a belief that the intervention would be ineffective. GPs involved in the trial took part in a 90-minute training programme to provide them with the skills and confidence to deliver the intervention, as well as handle difficult questions.
Professor Paul Aveyard of the University of Oxford’s Nuffield Department of Primary Care Health Sciences, lead author of the study and a practising GP, said: ‘Doctors can be concerned about offending their patients by discussing their weight, but evidence from this trial shows that they should be much less worried. Our study found that a brief, 30-second conversation, followed by help booking the first appointment on to a community weight loss programme, leads to weight loss and is welcomed by patients. On average, people consult their doctor five times a year, meaning there is huge opportunity to deliver this low-cost intervention on a large scale.’
The study did not directly assess participants’ desire, intention or confidence to achieve weight loss, but the research team excluded people who were already taking part in weight loss programmes, suggesting most people in the trial had low motivation to lose weight. The study took place across the south of England, and the participants were slightly more affluent on average than England as a whole. The results are likely generalisable to other countries where similar weight-loss programmes are offered free of charge (for example, the UK, Australia or Germany).
Estimating the cost of the intervention, the authors say that the 30 seconds costs approximately £1.45, and the 12-week behavioural programme costs about £50. Booking the participant’s place on the weight-loss programme could be done by administrative staff at GP practices, such as receptionists, at a cost of approximately £0.76 for the two minutes it takes to find a convenient time and transfer voucher details.
Given 40% attended the weight loss programme, each time a GP intervenes in this way would cost the NHS about £22 – equivalent to a cost per kg of £16 over 12 months, which is much lower than other available interventions for obesity, for instance prescription pharmaceuticals.
Writing in a linked comment piece for The Lancet, Professors Boyd Swinburn and Bruce Arroll of the School of Population Health, University of Auckland, New Zealand say the findings ‘provide optimistic news for the management of obesity in primary care’. They add: ‘The positive results of the 30-second active intervention signal a need for further such studies so that the evidence base for brief interventions for weight management matches that for quitting smoking, exercise prescriptions, and alcohol problems. This brief intervention as part of a usual consultation capitalises on opportunities within the current systems of primary care practice.’
The paper ‘Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial’ is published in The Lancet.